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Abstract: Immunocontraceptive vaccines based on gonadotropin-releasing hormone 
(GnRH) have been tested in adult white-tailed deer (Odocoileus virginianus), but their effects 
on fawns are unknown. The purpose of this study was to determine if early immunization 
against GnRH would induce a long-lasting immune response in fawns, and if it would delay 
or prevent sexual development. We gave primary and subsequent booster injections of a 
KLH-GnRH/Freund’s vaccine to 6 male and 6 female fawns. This vaccine contained the 
same active ingredients as GonaCon™ vaccine, but it contained Freund’s adjuvant instead 
of AdjuVac™ adjuvant. Two 450-μg injections were given 1 month apart when fawns were 3 
and 4 months of age. Although 1 female fawn produced a multiyear contraceptive response 
similar to that observed previously in vaccinated adults, the immune response lasted only 
1 year in the other 11 fawns. Antibody titers in those 11 fawns declined sharply to near 
zero during the second and third years after vaccination. Our results indicate that treating 
3- to 4-month-old white-tailed deer with the GnRH vaccine did not induce contraception or 
sterilization, and it did not delay or prevent sexual development. No adverse health effects 
were apparent in GnRH-treated fawns.
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Deer–vehicle collisions (DVCs) and other 
deer–human confl icts are becoming more fre-
quent in rural areas (Storm et al. 2007), suburbia 
(Hussain et al. 2007), and urban areas. DVCs 
cause damage to vehicles and injuries and 
fatalities to humans (Conover 1997, 2001). There 
are no panaceas for reducing the frequencies of 
DVCs, but reducing deer densities may be 1 
option. There is great interest in developing an 
eff ective method to contracept deer as a way to 
lower local deer densities and DVCs.
Adult white-tailed deer (Odocoileus virgini-
anus) of both sexes have been temporarily 
rendered infertile by vaccination with an im-
munocontraceptive vaccine consisting of a 
gonadotropin-releasing hormone (GnRH) 
conjugate combined with Freund’s adjuvant 
(Miller et al. 2000). Vaccines used in early 
studies consisted of GnRH conjugated to 
a mollusk carrier protein (keyhole limpet 
hemocyanin, or KLH). The large size and 
foreign (non-self) nature of KLH greatly in-
creased the immunogenicity of GnRH, which 
(if unconjugated) is a weak antigen. Multiple 
(primary and subsequent booster) injections 
of vaccine were used to induce strong immune 
responses in adult white-tailed deer (Miller et 
al. 2000, Miller and Killian 2001). A diff erent 
mollusk protein (blue protein) has been used in 
place of KLH since 2004 as a carrier molecule to 
which synthetic GnRH is att ached. Both KLH 
and blue protein formulations of GonaCon™ 
are emulsifi ed with a newly developed adjuvant 
called AdjuVac™.  AdjuVac replaced Freund’s 
adjuvant in the vaccine at the urging of the U.S. 
Food and Drug Administration due to concerns 
over Freund’s safety. 
An application was submitt ed to the U.S. 
Environmental Protection Agency during 2007 
for registration of GonaCon as a contraceptive 
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agent for use in female white-tailed deer. We 
anticipate that GonaCon will be registered as 
a restricted-use product that will be labeled 
for use by state and federal wildlife or natural 
resource management personnel or persons 
working under their authority. GonaCon users 
also will be required to follow state author-
ization processes and regulations.
GonaCon vaccine has been tested as a single-
injection contraceptive agent in domestic 
hogs (Sus scrofa; Miller et al. 2004b), feral hogs 
(Killian et al. 2004b, 2006c), bison (Bison bison; 
Miller et al. 2004a), California ground squirrels 
(Spermophilus beecheyi; Nash et al. 2004), feral 
cats (Felis catus; Levy et al. 2004), black-tailed 
deer (Odocoileus hemionus; Perry et al. 2006), and 
free-ranging horses (Equus caballus; Killian et al. 
2004a, 2006b). GonaCon has also been tested 
for toxicity in white-tailed deer (Killian et al. 
2006a). The results of these and other studies 
(Miller et al. 2004c) suggested that GonaCon 
vaccine is both safe and potentially useful as a 
wildlife contraceptive agent in a wide range of 
mammalian species. 
The contraceptive eff ect of vaccination with 
GonaCon was greater and longer lasting in 
females than in males (Killian et al. 2004b, 2006c). 
Male deer treated with GonaCon exhibited ab-
normal antler development associated with 
reduced serum androgens. These fi ndings 
prompted our recommendation that GonaCon 
vaccine use in deer be limited to treatment of 
females (Killian et al. 2005).
Reproductive inhibitors must be tailored 
to the physiology of the target animal, as no 
contraceptive agent is eff ective, practical, and 
appropriate for use in all species (Fagerstone 
et al. 2002) or age classes. Although GonaCon 
safely and eff ectively causes temporary infer-
tility in adult deer, its eff ects on fawns are 
unknown. This paper describes eff orts to de-
termine whether injecting 3-month-old white-
tailed deer fawns with GonaCon vaccine would 
induce a long-lasting immune response or aff ect 
sexual development.
Methods
White-tailed deer fawns used in this study 
were born and maintained at the Pennsylvania 
State University (PSU) Deer Research Center 
in University Park, Pennsylvania, where they 
were kept in outdoor paddocks that ranged 
in size from 0.12 ha to 1.5 ha (0.3 acres to 3.8 
acres). Vegetation in the paddocks consisted 
of a mixture of clover and orchard grasses and 
eastern deciduous forest. The study was ap-
proved by the Institutional Animal Care and 
Use Committ ee of PSU.
Six male and 6 female white-tailed deer fawns 
each were given 2 injections of 450-μg KLH-
GnRH-Freund’s vaccine; a primary injection was 
given at 3 months, and a booster injection was 
given at 4 months of age. Blood samples were 
collected from all fawns in September before the 
primary injection, in October before the booster 
injection, and during the following Novemb-
er and February. Blood was centrifuged, and 
progesterone concentrations and anti-GnRH 
antibody titers were measured in the recovered 
serum. Similar collections and evaluations of 
blood samples occurred during the second 
and third years of the 3-year study, although 
no additional GnRH vaccinations were given. 
During the autumn breeding season each year, 
adult bucks of proven fertility were kept in the 
enclosure with the study deer to serve as sires. 
To determine pregnancy, ultrasonography was 
performed each February on every female fawn. 
We documented the development and shedding 
of antlers by males each year. We assessed the 
sexual development of the female fawns by 
measuring serum progesterone concentrations 
as an indicator of ovarian function. Evalu-
ation of males consisted of measuring serum 
testosterone concentrations and observing and 
documenting antler development and scrotal 
testis length.
Progesterone assay
We used the Coat-A-Coat™ Progesterone In-
vitro Diagnostic Test Kit (Diagnostic Products, 
Los Angeles, Calif.) in these studies, and we 
followed the manufacturer’s recommended 
procedure.
Antibody response
We used an enzyme-linked immunosorbent 
assay (ELISA) to assess immune responses to the 
GnRH vaccine. A 96-well plate was prepared by 
adding 100 ng of BSA (bovine serum albumin)-
GnRH antigen to each well and blocking with 
SeaBlock™ from Pierce Chemical (Rockford, 
Ill.). (Blocking prevented binding of antibody to 
plastic in the ELISA plate.) Because GnRH-KLH 
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was used in the vaccine, BSA-GnRH was put on 
the ELISA plate, and, thus, only antibodies to 
GnRH were detected.
We serially diluted deer blood serum from 
1:1,000 to 1: 256,000 in phosphate-buff ered 
saline containing SeaBlock. Antibodies in the 
deer serum to GnRH on the plate were dir-
ected with the following linkage: deer anti-
GnRH binds to the GnRH on the plate, rab-
bit anti-deer immunoglobulin G (IgG) binds 
to the deer IgG, goat anti-rabbit-peroxidase 
binds to the rabbit IgG. We used chromogen 
(tetramethylbenzidine) to develop the color 
and 2M H2SO4 to stop the reaction. We read 
the color intensity of the sample at 450 nm 
with a Dynatech MR 5000 ELISA plate reader 
(Dynatech Laboratories, Alexandria, Va.).
Results
Females
Antibody response. All female fawns respond-
ed to the primary and booster vaccinations 
by producing anti-GnRH antibody titers of 
1:128,000 by October or November 1998. In 5 
of these 6 fawns, however, titers subsequently 
dropped to nondetectable levels by February 
1999 (e.g., Figures 1, 2). The immune response 
of the sixth female fawn (no. 976) also had 
waned by February 1999, but then the animal 
appeared to self-boost, as the antibody level 
increased dramatically and remained elevated 
throughout the fi nal 2 years of the study (Figure 
3).
Ultrasonography. As expected, the initial 
ultrasound examinations during February 
1999 all indicated non-pregnancy because the 
fawns had been only 4 to 6 months old during 
the breeding season in fall 1998 (Figures 1‒3). 
During autumn 1999, 1 of the 6 female fawns 
died from severe pneumonia, and another 
died from chronic rumenitis. Both diseases 
are common causes of death in captive white-
tailed deer in Pennsylvania (Hatt el et al. 2004) 
and elsewhere in North America (Haigh et al. 
2005). Ultrasonography performed in February 
2000 and 2001 indicated pregnancy in 3 of the 
4 surviving fawns. All 3 of these fawns had 
had low anti-GnRH antibody titers 1 year aft er 
vaccination, and, thus, they probably no longer 
exhibited anti-GnRH contraceptive activity (in-
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FIGURE 1. (Female no. 968) A very strong initial immune response declined sharply to non-detectable levels 
within several months, and the doe produced twin fawns in 2000 and 2001. Peaks in serum progesterone 
concentrations during February 2000 and 2001 indicated pregnancy.
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Female Fawn 921
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FIGURE 2. (Female no. 921) A strong initial immune response declined to non-detectable levels within 
several months. Twin fawns were produced in 2000, and triplets were produced in 2001. Minor elevations in 
serum progesterone concentrations during winters probably indicated estrous cycling and pregnancy.
Female Fawn 976
0
50
100
150
200
250
300
9/
15
/9
8
10
/1
3/
98
11
/1
0/
98
2/
9/
99
9/
23
/9
9
10
/2
6/
99
11
/9
/9
9
2/
9/
00
9/
20
/0
0
11
/1
/0
0
2/
7/
01
Blood sampling date
A
n
ti
b
o
d
y 
ti
te
r-1
 (x
 1
,0
00
)
0
2
4
6
8
10
12
14
P
ro
g
es
te
ro
n
e 
(n
g
/m
l)
Anti-GnRH antibody titer Progesterone
U
ltr
as
ou
nd
 in
di
ca
te
d
no
t p
re
gn
an
t
U
ltr
as
ou
nd
 in
di
ca
te
d
no
t p
re
gn
an
t
U
ltr
as
ou
nd
 in
di
ca
te
d
no
t p
re
gn
an
t
FIGURE 3. (Female no. 976) A strong initial immune response began to decline and then sharply increased 
to a very high level by September 1999 due to an apparent self-boost. The anti-GnRH antibody level re-
mained elevated and provided a contraceptive effect throughout the remainder of the study.
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fertility; Figures 1, 2). In contrast, fawn no. 976 
apparently self-boosted between February and 
September 1999, and then maintained a high 
level of anti-GnRH antibody, was identifi ed as 
non-pregnant by ultrasound examination in all 
3 years, and remained infertile (Figure 3).
Progesterone. In blood samples collected dur-
ing the fall breeding seasons in 1998–2000, 
we observed only slight elevations in serum 
progesterone concentrations, probably asso-
ciated with the estrous cycle (Figures 1‒3). 
Mean monthly progesterone concentrations in 
September, October, and November (all 3 years) 
ranged from 0.1 to 1.5 ng/ml.
Fawn Production. As noted above, fawn no. 
976 was infertile throughout the study. During 
the second and third years of the study, the 3 
remaining fawns bore twins and triplets, with a 
mean of 2.3 fawns per doe per year.
Males
Antibody response. Anti-GnRH antibody res-
ponses generally were strong but of short dura-
tion (≤1 year). By October or November of the 
fi rst year (1998), 5 of the 6 males had produced 
antibody titers of at least 1:128,000. Male fawn 
957 produced a titer of 1:32,000 during the fi rst 
year, but this value declined to a nondetectable 
level by February 1999 (Figure 4). In November 
1999, one of the males with an initially high 
(1:128,000) titer died (cause unknown). Titers 
of the other 4 bucks that had initially produced 
high anti-GnRH titers dropped to the 1:4,000 to 
1:16,000 range during the fi rst year (Figure 5). 
During the third year, titers of 2 of these 4 mal-
es declined to nondetectable levels, while the 
remaining 2 males maintained titers of 1:2,000 
to 1:4,000.
Serum testosterone concentrations. As expected, 
serum testosterone concentrations in all male 
fawns were undetectable throughout the fi rst 
year, regardless of anti-GnRH antibody titers. 
Throughout the remainder of the study, all 
surviving males except one (fawn no. 957; 
Figure 4) maintained abnormally low tes-
tosterone concentrations (0.2 to 1.8 ng/ml dur-
ing the autumn rut). In contrast, during the 
second and third years of the study, male fawn 
no. 957 exhibited testosterone concentrations 
that ranged from 5.2 ng/ml to 13.5 ng/ml.
Antler development. Antler development in 
fawn number 957 was normal throughout the 
study. In the other surviving males, antler de-
velopment was reduced during the second year 
and was normal during the third year.
Scrotal testis length. Scrotal testis length in 
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FIGURE 4. (Male no. 957) A moderately strong initial immune response declined to non-detectable levels 
within several months. Sexual development in this male was not delayed; it followed the pattern typical of 
unvaccinated males.
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male fawn no. 957, which had the weakest 
immune response to the vaccine, was 70 mm 
and 84 mm, respectively, in the second and 
third years. Scrotal testis lengths among the 
remaining males ranged from 1.0 to 5.6 mm in 
the second year and from 5.1 to 8.3 mm in the 
third year.
Discussion
The strong initial immune responses of fe-
male and male fawns to vaccination with the 
KLH-GnRH/Freund’s formulation of GonaCon 
vaccine used in this study were similar to 
those observed previously in adult deer in-
jected with that vaccine formulation or with 
a more recently-developed GonaCon vaccine 
formulation that incorporated blue protein and 
AdjuVac adjuvant. Anti-GnRH antibody titers in 
the fawns, however, declined relatively rapidly. 
During the 3-month period before February 
1999, high initial antibody levels dropped shar-
ply to nondetectable levels in 5 of the 6 female 
fawns. Titers in male fawns declined more 
slowly than in females, but at a much more 
rapid rate than was observed previously in 
adults (Miller et al. 2000). An exception to the 
general patt ern exhibited by the fawns in this 
study was the anti-GnRH antibody patt ern 
observed in female fawn number 976 (Figure 
3), which was typical of that of adult does vac-
cinated with GonaCon (Miller et al. 2000).
Anti-GnRH antibody levels ≥1:64,000 gen-
erally are associated with infertility in adult 
white-tailed deer (Miller et al. 2000). In earlier 
studies, adult white-tailed does given primary 
and booster (1,000 μg per dose, given 2 months 
apart) injections of KLH-GnRH-AdjuVac vac-
cine typically remained infertile for up to 4 
years, with an apparent self-boosting eff ect 
oft en occurring during the fall of the third year 
(L. A. Miller, unpublished data). The failure of 
female and male fawns in this study to sustain 
an initially strong antibody response may be 
related to a lack of “immune maturity” (Tizard 
2000).
Elevated serum progesterone concentrations 
in 2 female fawns during November 1998 (6.0 
ng/ml in fawn no. 905 [not illustrated]; 2.9 ng/ml 
in fawn no. 921 [Figure 2]) may have indicated 
that these deer were cycling. As these fawns 
were about 5 months old at the time of blood 
sampling, these elevated concentrations may 
have been associated with estrus at puberty. 
All other elevated progesterone concentrations 
FIGURE 5. (Female no. 976) A very strong initial immune response dissipated within a year. Serum testos-
terone concentrations and antler growth were reduced through February 2001. By November 2001, the 
serum testosterone concentration had returned to the normal range.
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observed in this study were associated both 
with ultrasound examinations that indicated 
pregnancy and with subsequent fawning.
Although fawn  no. 976 was infertile through-
out the 3-year study, the other 3 surviving 
female fawns each produced an average of 2.3 
fawns per year during the last 2 years of the 
study. Mean fawn production among adult 
does in the PSU deer herd was 1.7 fawns per 
doe per year (Miller et al. 2000), with single 
fawns typically resulting from fi rst pregnan-
cies. The relatively high rates of twin and triplet 
production in the present study may be due to 
a rebound phenomenon related to the decrease 
in anti-GnRH antibody levels. Similar rates 
of twin and triplet production have not been 
observed in GnRH-vaccinated adult does. In 
fact, GnRH-treated adult deer oft en produce 
single fawns during the fi rst year aft er anti-
GnRH antbody titers have declined, and then 
twins are produced during subsequent years 
(G. J. Killian, unpublished data). 
Development of testes and antlers in cervids 
are directly related to testosterone levels (Verme 
and Ullrey 1984). Vaccination of adult male 
deer with GonaCon vaccine indirectly aff ects 
testicular and antler development by reducing 
testosterone concentrations (Killian et al. 2005). 
Mean scrotal testis length in adult deer in 
the PSU deer herd is 74 mm, in contrast to a 
mean length of 40 mm in GnRH-treated adult 
bucks (Killian et al. 2005). Although testicular 
development in male fawn no. 957 was normal, 
it was greatly suppressed in the other male 
fawns in which testes remained substantially 
smaller than normal during the third year of 
the study. The comparatively weak and short-
lived immune response by male fawn no. 957 
suppressed serum testosterone concentrations 
only briefl y, and it appeared to have no long-
term contraceptive or developmental eff ects. 
On the other hand, the other male fawns 
showed stronger and longer-lasting immune 
responses to vaccination with GonaCon. In 
those males, testosterone suppression persisted 
into the second and third years, with a resultant 
reduction in the developmental rates of testes 
and antlers.
GonaCon’s multiyear contraceptive eff ect 
appears to be due to antigen retention caused 
by a water-in-oil emulsion that provides a slow 
release of the antigen from the injection depot 
site. The retained antigen (GnRH) is present 
long enough that the antibody combines with 
GnRH to form GnRH-specifi c immune com-
plexes (ICs). Retention of these ICs through 
their binding to follicular dendritic cells (FDCs) 
provides 2 functions: (1) it increases the duration 
of the antigen’s stimulatory eff ects by protecting 
the antigen from destruction by macrophages, 
and (2) it dramatically increases the strength 
of the immune response through self-boosting. 
Bound FDCs and ICs sett le into the draining 
lymph node where they are closely surrounded 
by B-cells to form a germinal center. Due to this 
proximity, 1 ng of GnRH released from the FDC 
in the draining lymph node can provide a self-
boost to the immune system similar in strength 
to the boosting eff ect of μg quantities of the same 
antigen in the original vaccine injection. The 
boosting eff ect from the draining lymph node 
could, therefore, be 1,000 times the strength of 
the initial reaction. The release of GnRH from 
the ICs in the lymph node is increased as the 
serum anti-GnRH antibody drops, whereas it 
is suppressed in the presence of high antibody 
levels (Burton et al. 1991, 1994).
In the treated fawns in this study, the 
mechanism that supports FDCs and ICs with 
the formation of the germinal center may not 
have been suffi  ciently developed to produce 
a normal, adult-like, multiyear contraceptive 
response, with the exception of female fawn no. 
976. Endogenous GnRH from the hypothalami 
of these immature fawns may not have been 
released in quantities suffi  cient to produce im-
mune complexes with the circulating, induced 
antibody. Without the binding of FDCs to ICs, 
a long-term immune response cannot develop 
(Burton et al. 1991, 1994).
Perhaps if the fawns in this study had been 
several months older when vaccinated, sexual 
development already would have been under-
way, and the associated release of endogenous 
GnRH from the hypothalamus already would 
have occurred. Had that been the case, the in-
jection of GnRH vaccine might have caused 
the formation of GnRH and anti-GnRH ICs 
and prompted the self-boosting immunity 
previously observed in GonaCon-treated, adult 
white-tailed deer. Our results indicate that 
treating 3-month-old white-tailed deer fawns 
with GnRH vaccine, although safe for the fawns, 
is not an eff ective means of inducing temporary 
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contraception, permanent sterilization, or the 
delay or prevention of sexual development.
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